90 related articles for article (PubMed ID: 3172091)
1. The effect of age on piroxicam disposition in rheumatoid arthritis.
Blocka KL; Richardson CJ; Wallace SM; Ross SG; Verbeeck RK
J Rheumatol; 1988; 15(5):757-63. PubMed ID: 3172091
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy, safety, and pharmacokinetic profiles of extended-release ketoprofen and piroxicam in patients with rheumatoid arthritis.
Caldwell JR
Clin Ther; 1994; 16(2):222-35. PubMed ID: 8062318
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of piroxicam: new aspects.
Fenner H
Eur J Rheumatol Inflamm; 1987; 8(1):42-8. PubMed ID: 3622592
[TBL] [Abstract][Full Text] [Related]
4. Anti-prostaglandin and anti-inflammatory short-term efficacy of piroxicam in rheumatoid arthritis.
Strusberg A; Montrull H; Meirovich CI
Eur J Rheumatol Inflamm; 1983; 6(1):41-5. PubMed ID: 6574910
[TBL] [Abstract][Full Text] [Related]
5. Plasma and synovial fluid concentrations of piroxicam during prolonged treatment with piroxicam pivalic ester.
Chérié Lignière G; Montagnani G; Alberici M; Acerbi D
Arzneimittelforschung; 1987 May; 37(5):560-3. PubMed ID: 3619977
[TBL] [Abstract][Full Text] [Related]
6. [Synovial tissue levels in comparison with synovial fluid and serum concentrations following a single daily administration of 20 mg piroxicam (Felden)].
Thabe H; Fassbender HG; Laufen H; Gierend M
Z Rheumatol; 1986; 45(5):271-6. PubMed ID: 3811635
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory changes produced by piroxicam in rheumatoid arthritis.
De Zubiria RC; Charria A; Lobo Guerrero D
Eur J Rheumatol Inflamm; 1983; 6(1):56-62. PubMed ID: 6861814
[TBL] [Abstract][Full Text] [Related]
8. Transsynovial kinetics of piroxicam in patients with rheumatoid arthritis.
Kurowski M; Dunky A
Eur J Clin Pharmacol; 1988; 34(4):401-6. PubMed ID: 3402526
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study on piroxicam at the steady-state in elderly subjects and younger adults after administration of piroxicam beta-cyclodextrin.
Acerbi D; Bonati C; Boscarino G; Bufalino L; Cesari F; D'Ambrosio E; Mansanti P; Scali G
Int J Clin Pharmacol Res; 1988; 8(3):175-80. PubMed ID: 3403105
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of piroxicam.
Verbeeck RK; Richardson CJ; Blocka KL
J Rheumatol; 1986 Aug; 13(4):789-96. PubMed ID: 3490574
[TBL] [Abstract][Full Text] [Related]
11. Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis.
Trnavská Z; Trnavský K; Zlnay D
Eur J Clin Pharmacol; 1984; 26(4):457-61. PubMed ID: 6734706
[TBL] [Abstract][Full Text] [Related]
12. Piroxicam pharmacokinetics: recent clinical results relating kinetics and plasma levels to age, sex, and adverse effects.
Hobbs DC
Am J Med; 1986 Nov; 81(5B):22-8. PubMed ID: 3538867
[TBL] [Abstract][Full Text] [Related]
13. Piroxicam versus naproxen in rheumatoid arthritis: a double-blind, cross-over study.
Larsen A
Int J Clin Pharmacol Res; 1985; 5(1):17-23. PubMed ID: 3888863
[TBL] [Abstract][Full Text] [Related]
14. Piroxicam and 5'-hydroxypiroxicam kinetics following multiple dose administration of piroxicam.
Richardson CJ; Blocka KL; Ross SG; Verbeeck RK
Eur J Clin Pharmacol; 1987; 32(1):89-91. PubMed ID: 3582473
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic disposition of isoxicam in hepatic cirrhosis.
Esquivel M; Ogilvie RI; East DS; Shaw DH; Heathcote J
Clin Invest Med; 1987 Sep; 10(5):363-7. PubMed ID: 3677504
[TBL] [Abstract][Full Text] [Related]
16. Comparison of diflunisal and piroxicam in the management of patients with rheumatoid arthritis.
Rice DM
Clin Ther; 1987; 10(1):92-7. PubMed ID: 3329968
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of piroxicam in elderly persons with and without renal impairment.
Rudy AC; Figueroa NL; Hall SD; Brater DC
Br J Clin Pharmacol; 1994 Jan; 37(1):1-5. PubMed ID: 8148211
[TBL] [Abstract][Full Text] [Related]
18. Double-blind crossover comparison of piroxicam and indomethacin in rheumatoid arthritis.
Domljan Z; Durrigl T
Eur J Rheumatol Inflamm; 1983; 6(3):291-6. PubMed ID: 6391934
[TBL] [Abstract][Full Text] [Related]
19. Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations.
Day RO; Francis H; Vial J; Geisslinger G; Williams KM
J Rheumatol; 1995 Dec; 22(12):2295-303. PubMed ID: 8835565
[TBL] [Abstract][Full Text] [Related]
20. Piroxicam suppositories for osteoarthritis and rheumatoid arthritis: an open multicentre study in 116 patients.
Heynen G; Dessain P
Eur J Rheumatol Inflamm; 1983; 6(1):134-8. PubMed ID: 6345164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
